Amarantus Bioscience Holdings Inc (OTC Pink - Current Information:AMBS)

0.0382
Delayed Data
As of 3:59pm ET
 -0.0048 / -11.11%
Today’s Change
0.01
Today|||52-Week Range
0.21
-72.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.7M

Company Description

Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.

Contact Information

Amarantus Bioscience Holdings, Inc.
953 Indiana Street
San Francisco California 94104
P:(408) 737-2734
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Gerald E. CommissiongPresident, Chief Executive Officer & Director
Barney MonteChief Operating & Financial Officer
John W. CommissiongDirector & Chief Scientific Officer
Robert L. HarrisIndependent Director & Compliance Officer
Elise BrownellSenior VP-Operations & Program Management